הבדלים בין גרסאות בדף "אלופורינול - Allopurinol"

אלופורינול - Allopurinol
התוויות	Management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). Management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.

גרסה מ־22:55, 25 ביולי 2013

אלופורינול - Allopurinol
שמות מסחריים	®ALLORIL


קבוצה פרמקולוגית (ATC)	"PREPARATIONS INHIBITING URIC ACID PRODUCTION"
שם התרופה	"אלופורינול" (קישור לדף התרופה במאגר משרד הבריאות)
סל הבריאות	כלול
התוויות	Management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis and/or nephropathy). Management of patients with leukemia, lymphoma, and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.
שם יצרן	DEXXON LTD
שם בעל הרישום	DEXXON LTD
עלון לצרכן	"עלון לצרכן בעברית,ערבית ואנגלית"